Neogen (NEOG) Expected to Announce Quarterly Earnings on Tuesday

Neogen (NASDAQ:NEOG) is projected to announce its Q4 2025 earnings results before the market opens on Tuesday, July 29th. Analysts expect the company to announce earnings of $0.09 per share and revenue of $222.52 million for the quarter.

Neogen Stock Up 2.0%

Shares of NASDAQ NEOG opened at $5.22 on Friday. Neogen has a 52 week low of $3.87 and a 52 week high of $18.58. The business has a 50-day simple moving average of $5.38 and a two-hundred day simple moving average of $7.51. The company has a quick ratio of 2.45, a current ratio of 3.91 and a debt-to-equity ratio of 0.33. The company has a market cap of $1.13 billion, a P/E ratio of -2.34 and a beta of 1.77.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on NEOG shares. Piper Sandler dropped their price target on Neogen from $6.40 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, April 22nd. Guggenheim dropped their price target on Neogen from $13.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, June 30th.

Insider Activity

In other Neogen news, Director Aashima Gupta purchased 16,000 shares of the company’s stock in a transaction dated Monday, May 12th. The stock was purchased at an average price of $6.25 per share, for a total transaction of $100,000.00. Following the transaction, the director owned 21,917 shares in the company, valued at $136,981.25. The trade was a 270.41% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.13% of the company’s stock.

Institutional Trading of Neogen

A number of large investors have recently modified their holdings of the business. United Services Automobile Association bought a new stake in shares of Neogen during the 1st quarter valued at about $112,000. Goldman Sachs Group Inc. lifted its position in Neogen by 14.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock worth $14,553,000 after buying an additional 209,990 shares during the last quarter. Jones Financial Companies Lllp lifted its position in Neogen by 5,687.3% in the 1st quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock worth $290,000 after buying an additional 32,816 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Neogen by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock worth $1,125,000 after buying an additional 5,638 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in Neogen by 217.0% in the 1st quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock worth $443,000 after buying an additional 35,878 shares during the last quarter. Institutional investors own 96.73% of the company’s stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.